Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03672396 · ClinicalTrials.gov registry record · NA
Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer
A NA study of Castration-resistant Prostate Cancer and Androgen Deprivation Therapy, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 2
- Study locations
NCT03672396: Completed NA study of Castration-resistant Prostate Cancer and Androgen Deprivation Therapy, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT03672396 is a NA study of Castration-resistant Prostate Cancer and Androgen Deprivation Therapy that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 22 participants, below the 216-participant average among 15 other Castration-resistant Prostate Cancer trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03672396, a NA study of Castration-resistant Prostate Cancer and Androgen Deprivation Therapy, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 2
- Study locations
Study Summary
This single arm, multi-site pilot study aims to evaluate the feasibility of recruiting and adherence to a 12 week home-based exercise intervention to be conducted in men with metastatic castration resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Thirty patients will be enrolled, with the expectation that 20-25 will complete all follow-up measures.
Primary Outcome
To estimate the feasibility of a 12 week, home-based exercise intervention in metastatic castrate resistant prostate cancer (mCPRC) patients undergoing androgen deprivation therapy by reporting the percentage of patients who complete the pre/post testing following the intervention. This was calculated as the number of subjects who completed the trial compared to the total number who completed baseline testing.
Conditions Studied
Interventions
- BEHAVIORAL Home-based exercise
Study Locations (2)
North Carolina
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill - Chapel Hill
- Comprehensive Cancer Center, Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT03672396 record still lists
NCT03672396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 216-participant average among 15 other Castration-resistant Prostate Cancer trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Castration-resistant Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Home-based exercise is the first listed.
NCT03672396 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03672396 about?
NCT03672396 is a clinical study titled "Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer". This single arm, multi-site pilot study aims to evaluate the feasibility of recruiting and adherence to a 12 week home-based exercise intervention to be conducted in men with metastatic castration resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Thirty patients will be...
What is the current status of trial NCT03672396?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-04-01. Estimated completion is 2019-12-31.
What conditions does trial NCT03672396 study?
This clinical trial studies the following conditions: Castration-resistant Prostate Cancer, Androgen Deprivation Therapy.
What interventions are being tested in trial NCT03672396?
The interventions under investigation include: Home-based exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03672396?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03672396 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Castration-resistant Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03672396's enrollment target sits among peer trials
22 16th of 15 the lowest of 15 other Castration-resistant Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Castration-resistant Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer
RECRUITING · Phase 2
-
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
RECRUITING
-
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
RECRUITING · Phase 1
-
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
RECRUITING · Phase 2
-
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
RECRUITING · Phase 1
-
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI